Plain-English translation of NCT07351786 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand how newer diabetes medications — such as SGLT2 inhibitors and DPP-4 inhibitors — affect diabetic retinopathy, which is eye damage caused by diabetes. This study will compare people taking newer medications with those taking older, classical diabetes drugs to see if there are differences in how their eyes are affected by diabetes.
Diabetic eye damage is a serious complication that can lead to vision loss. Doctors want to know whether the newer medications available today offer better protection for the eyes compared to older treatments.
You likely qualify if…
You likely don't qualify if…
This is a research study where you share information about your diabetes treatment and medical history — no new medications or procedures are involved. Researchers will review your medical records and compare eye health outcomes between people taking newer diabetes drugs and those taking older medications to understand which treatments may better protect vision.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Egypt
Enrollment target
~70 participants
Started
August 2025
Primary completion
August 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
25 Years and older
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Sara A Belal
Sara A Belal
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.